Blue Water Biotech announced an agreement with Knipper Health to manage the inventory and distribution of product samples to sales representatives for ENTADFI and ZONTIVITY. As part of Blue Water’s product roll-out plans, Knipper Health will oversee sample inventory and ship samples on request to the sales force in the field. This will help to expedite physicians’ initiation of therapy for their patients while increasing familiarity with the products.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BWV:
- Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds
- Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians
- Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®
- Blue Water Biotech teams with UpScriptHealth to launch telemedicine platform
- Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities
